Related Experiment Video
Updated: Feb 28, 2026

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
T-bet Runs INTERFERence
Vanja Lazarevic1, Susanne Szabo2, Laurie H Glimcher3
1Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
In this issue of Immunity, Iwata et al. (2017) report that the transcription factor T-bet acts as a selective repressor of the type I interferon (IFN) transcriptional program in response to IFN-γ signaling.
In this issue of Immunity, Iwata et al. (2017) report that the transcription factor T-bet acts as a selective repressor of the type I interferon (IFN) transcriptional program in response to IFN-γ signaling.
Related Concept Videos
TGF - β Signaling Pathway
Tumor Immunotherapy
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

